Fepixnebart

A4DAB116 | Phase-II
EREG
G4 / None
Eli Lilly and Company
Phase-II
Whole mAb
LY-3016859 LY 3016859 LY3016859
—
IMGT PubChem (440234900) PubChem (462764887) PubChem (472420502) PubChem (485483321) PubChem (485511894) Thera-SAbDab YAbS
Avg A4D Score
-0.6451
Score Range
-0.65
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB116_5kn5_A_B 5kn5 100% -0.6451 6.5 4.0 -0.0287 -0.7262